Layer-by-layer engineered capsules and their applications
Introduction
Micro- and nanometer-sized capsules have found application in diverse areas, ranging from medicine and biotechnology to catalysis and synthetic chemistry. Since their introduction in 1998 [1], [2], capsules prepared via the layer-by-layer (LbL) technique [3] have attracted particular interest, largely because of the ability to readily tailor their properties (e.g., size, composition, porosity, stability, surface functionality, colloidal stability). In addition, the step-wise formation of these capsules allows the introduction of multiple functionalities, thus providing opportunities to engineer a new class of materials with unprecedented structure and function. For example, LbL capsules can be assembled from a suite of materials, including synthetic and natural polyelectrolytes, nanoparticles and biomacromolecules [4••]. A range of colloidal particles with sizes varying from nanometers to many micrometers, and composition spanning inorganic and polymer particles to those composed of biomacromolecules or low molecular weight species, can be used as the particle templates [4••], [5]. The capsule surface can be modified to alter the functionality and/or improve the colloidal stability of the capsules, and various materials can be sequestered into the capsule interior for drug delivery, sensing or catalysis applications.
LbL capsules are typically formed by the consecutive deposition of complementary/interacting polymers onto colloidal particles, followed by removal of the sacrificial colloidal template (Fig. 1) [4••], [5]. A large number of inorganic [2], [6] and polymer-based capsules assembled by the LbL method have been reported. In this review, we will focus on capsules prepared from polyelectrolytes, as the vast majority of capsules have been assembled by the alternate deposition of positively and negatively charged polymers, where electrostatic forces facilitate layer build-up. LbL assembly has been extended to films held together by hydrogen bonding [7], [8], hydrophobic interactions [9] and, more recently, hybridization of DNA base pairs [10], [11]. The latter approach has led to LbL capsules composed entirely of DNA with designed composition, structure and stability [10], [11]. Varying the layer number, the assembly conditions (e.g., salt concentration, pH) [12], [13] and the multilayer composition [14], [15] readily affords control over the properties of polyelectrolyte capsules.
In this review, we focus on the preparation and application of polyelectrolyte capsules as drug delivery vehicles, with particular emphasis on developments made in recent years. The principal advantage of capsule-based delivery vehicles [16] is that the capsule protects both the drug from degradation by the body and the body from side effects of the drug. For micro-/nanocapsules to have application as therapeutic delivery vehicles, three areas must be addressed: (i) encapsulation of the therapeutic, (ii) targeting of the capsules in biological systems and (iii) release of the therapeutic from the capsules. The different strategies used to encapsulate materials within LbL capsules will be addressed. The importance and potential of such capsules to target cells will be highlighted, and recent advances in releasing such materials from LbL capsules will be discussed. Additionally, the use of capsules in sensing applications will be briefly discussed.
Section snippets
Encapsulation of therapeutics in LbL capsules
A number of techniques have been proposed to incorporate therapeutics within micro- and nanocapsules. Fig. 2 depicts the three principle techniques.
A straightforward approach to load capsules is to exploit the diffusion of therapeutics from the surrounding medium in which the capsules are dispersed into the capsule interior (Fig. 2A). When the polyelectrolyte capsule shell is assembled from materials that are responsive to salt (e.g., dextran sulfate/poly(allylamine hydrochloride) (PAH)) [17]
Targeting of LbL capsules
The surface chemistry of the micro-/nanocapsules dictates how they behave within a biological environment. The aims of surface modification are, therefore, to prevent the body from recognizing the capsules as foreign material and to deliver the capsules to particular locations within the body by targeting to specific cell types.
If a micro-/nanocapsule is recognised by the body as a foreign object, it will be destroyed and excreted before it has delivered its cargo. Various coatings, including
Release of encapsulated materials
There are two distinct ways of releasing the therapeutic cargo once it has reached its intended location: instantly (burst release) or slowly over an extended period (sustained release). Burst release is appropriate when the capsules are to undergo intracellular uptake (e.g., chemotherapy, gene transfection), whereas sustained release is desirable when the capsules are to remain extracellular and so high doses of therapeutic may be dangerous and/or constant levels of drug are required (e.g., in
Sensing
Micro- and nanometer-sized capsules are also promising for application in the area of sensing. Miniaturization of sensing devices opens the possibility of detecting low concentrations of molecules in situ. LbL capsules have been used to sense small ions and oxygen [54] by immobilizing a fluorescent indicator inside the capsules. Sensing biomolecules (e.g., DNA) may also be achieved by immobilizing a molecular beacon (a molecular device that fluoresces upon binding of complementary DNA) inside
Conclusions
The application of micro-/nanocapsules as drug delivery vehicles shows great promise. The ability to direct the drug specifically to the area in the body where it is needed, to shield the drug from the body during its journey, and to deliver the drug in a controlled manner once it arrives at the targeted site, promises to dramatically improve the treatment of many diseases, from cancer to genetic disorders. There are, however, several challenges that must be addressed before these goals can be
Acknowledgements
This work was supported by the Australian Research Council under the Federation Fellowship and Discovery Project schemes, and by the Victorian State Government under the STI Initiative. John F. Quinn and Yajun Wang are thanked for critical reading of the manuscript.
References and recommended readings•,•• (56)
- et al.
Novel hollow polymer shells by colloid-templated assembly of polyelectrolytes
Angew Chem Int Ed
(1998) - et al.
Nanoengineering of inorganic and hybrid hollow spheres by colloidal templating
Science
(1998) Fuzzy nanoassemblies: toward layered polymeric multicomposites
Science
(1997)- et al.
Tailor-made polyelectrolyte microcapsules: from multilayers to smart containers
Angew Chem Int Ed
(2004) Nanoscale particle modification via sequential electrostatic assembly
- et al.
Multilayered titania, silica and laponite nanoparticle coatings on polystyrene colloidal templates and resulting inorganic hollow spheres
Chem Mater
(2001) - et al.
Molecular-level processing of conjugated polymers: layer-by-layer manipulation of polyaniline via hydrogen-bonding interactions
Macromolecules
(1997) - et al.
A new approach for the fabrication of an alternating multilayer film of poly(4-vinylpyridine) and poly(acrylic acid) based on hydrogen bonding
Macromol. Rapid Commun.
(1997) - et al.
Layer-by-layer assembly of poly(vinyl alcohol) and hydrophobic polymers based on their physical adsorption on surfaces
Langmuir
(2002) - et al.
DNA multilayer films on planar and colloidal supports: sequential assembly of like-charged polyelectrolytes
Nano Lett.
(2005)